Clinical Trial: A Study in Adults With Desmoid Tumors

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07541430) titled 'A Study in Adults With Desmoid Tumors' on March 31.

Brief Summary: This is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs), pharmacokinetics (PK), anti-drug antibody (ADA) and pharmacodynamics (PD) of ES014 in adult desmoid tumor patients.

Study Start Date: April 30

Study Type: INTERVENTIONAL

Condition: Desmoid Tumor

Intervention: DRUG: ES014

ES014 is administered via intravenous infusion, 700mg once every 14 days, every 28 days as a treatment cycle for a maximum treatment duration per patient of 2 years.

DRUG: ES014

ES0...